In vivo, IL-4 promotes M2-like macrophage phenotypes after stroke [55, 56], spinal cord injury (SCI) [57–59], and peripheral nerve injury (PNI) [22, 60] at doses ranging from 250 to 500 ng. The gene discussed is IL4; the disease is stroke disorder.